October 19, 2026 at 12:06 PM UTC
Silence Therapeutics plc reports material agreement in SEC 8-K
Silence Therapeutics plc filed an 8-K covering a material definitive agreement and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: October 19, 2026 at 12:05 PM UTC
Open official source